Bitcoin mining stock report: Core Scientific continues rally with a 72% gain

Quick Take

  • Despite most mining stocks falling, Core Scientific continued its rally by finishing up 72% today. 
  • CleanSpark and the U.S. and Canadian branches of Bitfarms fell the most. 

Despite most mining stocks falling, Core Scientific continued its rally by finishing up 72% today. 

Bitcoin was valued at around $17,400 at the close on Thursday, according to data from TradingView. The cryptocurrency steadily fell from its position of roughly $17,800 yesterday.  

BTC/USD price chart by TradingView

Core Scientific continued its rally by finishing up 72% today. The firm's shares gained 69% yesterday after B. Riley, one of its largest creditors, proposed a $72 million financing lifeline for the firm. Mawson Infrastructure Group ranked second in gains, rising 6.32%. 

THE SCOOP

Keep up with the latest news, trends, charts and views on crypto and DeFi with a new biweekly newsletter from The Block's Frank Chaparro

By signing-up you agree to our Terms of Service and Privacy Policy
By signing-up you agree to our Terms of Service and Privacy Policy

CleanSpark fell the most today, down 16.67%, followed by both the U.S. and Canadian companies of Bitfarms, down 12.2% and 11.11%, respectively. 

Here's how crypto mining companies performed on Thursday, Dec. 15:


© 2023 The Block. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

About Author

MK Manoylov has been a reporter for The Block since 2020 — joining just before bitcoin surpassed $20,000 for the first time. Since then, MK has written nearly 1,000 articles for the publication, covering any and all crypto news but with a penchant toward NFT, metaverse, web3 gaming, funding, crime, hack and crypto ecosystem stories. MK holds a graduate degree from New York University's Science, Health and Environmental Reporting Program (SHERP) and has also covered health topics for WebMD and Insider. You can follow MK on X @MManoylov and on LinkedIn.

Editor

To contact the editors of this story:
Madhu Unnikrishnan at
[email protected]
Michael McSweeney at
[email protected]